Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Operating Margin (2013 - 2026)

Updated

Theravance Biopharma's Operating Margin was -39.93% in Q2 2026, down 29.52 percentage points from -10.40% a year earlier but up 13.65 percentage points from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Operating Margin (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Theravance Biopharma's Operating Margin was -4.03% through Jun 30, 2026, up 44.15 percentage points year-over-year; for FY2025, it came in at -3.35%, up 69.57 percentage points from FY2024.

  • Operating Margin has now increased for four consecutive years, with a five-year change of +410.84 percentage points (FY2020 to FY2025).
  • In earlier years, Operating Margin was -72.92% in FY2024 (+24.66 pp), -97.58% in FY2023 (+81.51 pp), -179.09% in FY2022 (+286.97 pp) and -466.06% in FY2021 (-51.87 pp).
  • Quarterly Operating Margin has moved between -406.36% (Q3 2021) and 43.61% (Q4 2025) over five years.
  • Compared with a year earlier, Operating Margin was higher in four of the last eight quarters, with an average year-over-year change of +24.57 percentage points.
  • The best year-over-year quarter for Operating Margin over five years was Q3 2022 (a gain of 332.92 percentage points); the worst was Q2 2026 (a drop of 29.52 percentage points).
  • Per Business Quant data, TBPH's Operating Margin in the three quarters before Q2 2026 was -53.58% (Q1 2026), 43.61% (Q4 2025) and -32.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Theravance Biopharma 883.70 Mn -543.66 Mn - -39.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -39.93%
Mar 31, 2026 -53.58%
Dec 31, 2025 43.61%
Sep 30, 2025 -32.29%
Jun 30, 2025 -10.40%
Mar 31, 2025 -93.80%
Dec 31, 2024 -49.06%
Sep 30, 2024 -64.25%
Jun 30, 2024 -110.16%
Mar 31, 2024 -77.27%
Dec 31, 2023 -35.53%
Sep 30, 2023 -55.82%
Jun 30, 2023 -117.27%
Mar 31, 2023 -239.15%
Dec 31, 2022 -119.00%
Sep 30, 2022 -73.44%
Jun 30, 2022 -243.25%
Mar 31, 2022 -291.77%
Dec 31, 2021 -375.80%
Sep 30, 2021 -406.36%
API Access

Theravance Biopharma Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEY